Tekla World Healthcare Fund:THW

    Manage Alerts


    As of 7/3/2022. NAV as of 7/1/2022.

    52 Wk Avg$15.97$15.076.00%
    52 Wk High$17.38$16.2217.21%
    52 Wk Low$13.29$12.40-2.14%
    Regular Distribution TypeManaged Distribution
    Distribution Rate9.58%
    Distribution Amount$0.1167
    Distribution FrequencyMonthly
    Past performance is no guarantee of future results.

    Basic Information

    Investment Objective

    The Trust's investment objective is to seek current income and long-term capital appreciation. The Fund may invest up to 20% of managed assets, measured at the time of investment, in non-convertible debt of healthcare companies. It may also invest up to 20% of managed assets in healthcare REITs. The Fund may also hold up to 30% of managed assets in convertible securities and may invest a portion of its assets in restricted securities.

    Capital Structure

    As of 7/3/2022

    Total Investment Exposure:$620.726M
    Total Common Assets:$500.726M
    Common Shares Outstanding:37,447,139

    As of 7/1/2022

    Preferred Share Assets:
    Total Debt (USD): $120.000M
    Regulatory Leverage (USD): $120.000M
    Effective Leverage (USD): $120.000M
    Effective Leverage (%): 19.33%
    Annual Expense Ratios

    As of 9/30/2021

      Per Common Share
    Management Fees1.25%
    Other Expenses:0.26%
    Baseline Expense: N/A
    Interest Expense:0.23%
    Total: 1.74%
    Fund Management

    Fund Sponsor
    Tekla Capital Management LLC

    Portfolio Managers
    Daniel R. Omstead

    Category: Equity-Sector Equity
    Ticker: THW
    NAV Ticker: XTHWX
    Average Daily Volume (shares): 119,232
    Average Daily Volume (USD): $1.875M
    Inception Date: 6/26/2015
    Inception Share Price: $20.00
    Inception NAV: $19.06
    Tender Offer: No
    Term: No
    Fiscal Year End: September 30
    Third Party Links & Reports


    As of 7/3/2022

    Past performance is no guarantee of future results.
    Distribution History

    Enter declared start and end dates to display distribution history below. Income, Long Gain, Short Gain and ROC breakdowns will only be shown for the past year.

    Declared Date Payable Date Ex Date Distrib Amount Income Long Gain Short Gain ROC

    *Indicates a Special Distribution: A distribution disbursed in addition to the normal distributions paid out by the company.

    Key Information Regarding Distributions
    Avg. Earnings Per Share:
    As of 3/31/2022
    Annualized Distribution Rate on NAV:
    As of 7/3/2022
    Total Return on NAV (12 months):
    As of 7/3/2022
    Avg. Portfolio Coupon:
    As of 7/3/2022
    Total % Portfolio Effectively Leveraged:
    As of 7/3/2022

    Pricing Information

    Premium/Discount Information
    Past performance is no guarantee of future results.
    Premium/Discount Information

    As of 7/4/2022

    PeriodAvg Discount
    6 Month5.24%
    1 Year6.00%
    3 Year1.53%
    5 Year-2.06%

    As of 7/4/2022

    3 Month-0.44
    6 Month0.52
    1 Year0.66
    Pricing History
    Date NAV Premium / Discount


    Calendar Year Total Returns

    As of 6/30/2022
    Category: Morningstar US CEF Sector Equity

    Past 20 Years

    Return YearPriceNAVCategory - PriceCategory - NAV
    Past performance is no guarantee of future results.
    Annualized Total Returns

    Returns for periods less than one year are cumulative rather than annualized

    As of 6/30/2022
    Category: Morningstar US CEF Sector Equity

    Past performance is no guarantee of future results.

    Portfolio Characteristics

    Portfolio Characteristics
    Average Coupon:
    As of 7/1/2022
    Number of Holdings:
    As of 3/31/2022
    Annual Portfolio Turnover:
    As of 9/30/2021
    Asset Allocation

    As of 3/31/2022

    Top Sectors

    As of 3/31/2022

    Defensive (Super Sector)100.28%
    Corporate (Super Sector)13.68%
    Corporate Bond11.89%
    Real Estate5.55%
    Cyclical (Super Sector)5.55%
    Cash Equivalents (Super Sector)3.09%
    Cash Equivalents3.09%
    Preferred Stock1.79%
    Future Forward-0.12%
    Top Holdings

    As of 3/31/2022

    HoldingValue% Portfolio
    UnitedHealth Group Inc$42.56M7.71%
    Roche Holding AG ADR$29.82M5.40%
    AstraZeneca PLC ADR$25.41M4.61%
    Pfizer Inc$21.58M3.91%
    Johnson & Johnson$21.07M3.82%
    Abbott Laboratories$20.11M3.64%
    AbbVie Inc$19.55M3.54%
    Novo Nordisk A/S ADR$17.05M3.09%
    McKesson Corp$16.64M3.02%
    Other Liability$-127.74M-23.15%
    Credit Quality

    As of 3/31/2022

    Maturity Breakdown

    As of 3/31/2022

    Country Allocation

    As of 3/31/2022

    Country% Portfolio
    United States - Equity77.78%
    Switzerland - Equity8.76%
    United States - Fixed Income8.56%
    United Kingdom - Equity6.01%
    Denmark - Equity3.06%
    Japan - Equity2.98%
    Germany - Equity1.74%
    United Kingdom - Fixed Income1.73%
    Australia - Equity1.41%
    France - Equity1.15%
    Ireland - Equity1.03%
    Netherlands - Equity0.91%
    Germany - Fixed Income0.73%
    France - Fixed Income0.49%
    Switzerland - Fixed Income0.39%
    Italy - Equity0.26%
    China - Equity0.25%
    Israel - Equity0.15%
    Canada - Equity0.01%

    Closed-end fund historical distribution sources have included net investment income, realized gains, and return of capital. For more detailed information on the distributions of a specific fund, please visit the sponsor's website.


    Distribution type sourced from Morningstar. In general, managed distributions may be sourced from net investment income, realized gains and return of capital. CEFConnect.com does not undertake to disclose specific information about closed-end fund distribution sources. For specific information about a fund's distribution sources, visit the fund sponsor's website.

    The following information applies to closed-end funds in general: Fund shares are not guaranteed or endorsed by any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation. Shares of closed-end funds are subject to investment risks, including the possible loss of principal invested. There can be no assurance that fund objectives will be achieved. Closed-end funds frequently trade at a discount to their net asset value. NAV returns are net of fund expenses, and assume reinvestment of distributions.